Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis

NCT01279629 · clinicaltrials.gov ↗

SUSPENDED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Each patient will receive a sample of the drug test (tazarotene 0.1%) and a control sample of the drug (calcipotriene 0.005%).

Sponsor

Glenmark Farmacêutica Ltda